Export and Investment Fund of Denmark (EIFO)
Investor profile
Investment firmVenture capital
Also recorded as: The Export and Investment Fund of Denmark (EIFO)
Deals
20
distinct rounds
Companies
19
backed
Active span
2023–2026
4 yrs
Total round €
€374M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Novo Holdings4
- Chr. Augustinus Fabrikker3
- Antler2
- Ada Ventures1
- Bill and Melinda Gates Foundation1
- Camilla Giesecke1
- Carsten Stendevad1
- Cipio Partners1
- Cormorant1
- Dawn Biopharma1
- Eli Lilly1
- Eneco Ventures1
- European Investment Bank (EIB)1
- Existing Shareholders1
- Forbion1
- Gilde Healthcare1
- Hearst Ventures1
- Helen Ventures1
- Helge Munk1
- HSBC Innovation Banking1
- INKEF Capital1
- Innovestor1
- Investo Capital1
- Join Capital1
- Jolt Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Orbis Medicines | Denmark | 1 | €90M |
| Antag Therapeutics | Denmark | 1 | €80M |
| MATR Foods | Denmark | 1 | €40M |
| Keepit | Netherlands | 1 | €37M |
| NIL Technology | Denmark | 1 | €29M |
| Eupry | Denmark | 1 | €23M |
| Draupnir Bio | Denmark | 1 | €12M |
| Dawn Health | Denmark | 2 | €12M |
| Freya Biosciences | Denmark | 1 | €11M |
| Blue World Technologies | Denmark | 1 | €11M |
| Creative Force | Denmark | 1 | €8.4M |
| QuadSAT | Denmark | 1 | €5.0M |
| Klimate | Denmark | 1 | €3.5M |
| Ward 24/7 | Denmark | 1 | €3.4M |
| Kvasir Technologies | Denmark | 1 | €3.0M |
| Interhuman AI | Denmark | 1 | €2.0M |
| Marts | Denmark | 1 | €1.8M |
| VentriJect | Denmark | 1 | €1.7M |
| Virtuall | Denmark | 1 | €829k |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Orbis Medicines | Series A | €90M | 2025-01 |
| Antag Therapeutics | Series A | €80M | 2024-12 |
| MATR Foods | Series A | €40M | 2025-10 |
| Keepit | Other | €37M | 2024-01 |
| NIL Technology | Other | €29M | 2024-05 |
| Eupry | Series A | €23M | 2025-01 |
| Draupnir Bio | Seed | €12M | 2024-07 |
| Dawn Health | Other | €12M | 2025-05 |
| Freya Biosciences | Other | €11M | 2024-11 |
| Blue World Technologies | Series C | €11M | 2023-12 |